-
Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027
Despite constraints due to the coronavirus pandemic, the Paris-based IRDiRC continues efforts for 1,000 new therapies and better rare disease care by 2027. Click here to read more.
Do you believe this goal is attainable? Why or why not?
Sorry, there were no replies found.
Log in to reply.